FDA Approved: ATELVIA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for Atelvia (risendronate sodium), resulting in an approved label-related update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• ATELVIA (RISENDRONATE SODIUM)

Snippet

SUPPL AP for ATELVIA (RISEDRONATE SODIUM)